Tonix Pharmaceuticals (TNXP) - 2024 Q4 - Annual Results

Loan Amount and Payment Terms - The total outstanding amount due under the Loan Documents is $8,650,000, plus additional charges totaling$1,122,151.17, resulting in a Combined Payoff Amount of $9,772,151.17[2] - The payment must be received by 4:00 p.m. (New York City time) on February 3, 2025, to avoid any prepayment penalties[3] - If the Combined Payoff Amount is received after the deadline, a per diem charge of$3,546.50 will be added for each day until full payment is received[4] - Upon receipt of the Combined Payoff Amount, all indebtedness of the Borrowers to the Lenders will be fully paid and discharged[5] Borrowers' Obligations and Lenders' Rights - The Loan Parties confirm that they have no defenses or claims against the Lenders related to the Loan Documents[8] - The Borrowers are required to execute additional documents as reasonably requested by the Lenders to effectuate the terms of the agreement[10] - The agreement includes provisions for the release of security interests and guarantees upon payment[5] - The Lenders will not have any further obligation to provide loans or credit extensions to the Borrowers after the payment is made[6] Agreement Terms - The agreement is governed by the terms set forth in the Loan Agreement, and electronic signatures are considered valid[9] - The agreement constitutes the entire understanding between the parties regarding the subject matter[10]